EnglishLUPPI, Mario
Risultati 1 - 20 di 306 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | β-HHVs and HHV-8 in Lymphoproliferative Disorders. | 2011 | C. Quadrelli ;P. Barozzi;G. Riva;D. Vallerini ;E. Zanetti; L. Potenza ;F. Forghieri ;M. LUPPI |
| 2 | Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) | 2008 | P. Barozzi; G. Riva; B. Ruozi; G. Tosi; D. Belletti; L. Potenza; C. Quadrelli; D. Vallerini; E. Zanetti; M. Morselli; F. Forghieri; M. Maccaferri; A. Paolini; F. Volzone; M.A. Vandelli; F. Forni; G. Torelli; M. Luppi |
| 3 | Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers | 2016 | Cojutti, Piergiorgio; Candoni, Anna; Forghieri, Fabio; Isola, Miriam; Zannier, Maria Elena; Bigliardi, Sara; Luppi, Mario; Fanin, Renato; Pea, Federico |
| 4 | Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. International Collaborative Group. | 1999 | Cook PM; Whitby D; Calabro ML; Luppi M; Kakoola DN; Hjalgrim H; Ariyoshi K; Ensoli B; Davison AJ; Schulz TF. |
| 5 | Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response | 2014 | Iacobucci, Ilaria; Lonetti, Annalisa; Venturi, Claudia; Ferrari, Anna; Papayannidis, Cristina; Ottaviani, Emanuela; Abbenante, Maria Chiara; Paolini, Stefania; Bresciani, Paola; Potenza, Leonardo; Parisi, Sarah; Cattina, Federica; Soverini, Simona; Russo, Domenico; Luppi, Mario; Martinelli, Giovanni |
| 6 | An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts | 2014 | Forghieri, Fabio; Bigliardi, Sara; Morselli, Monica; Potenza, Leonardo; Fantuzzi, Valeria; Faglioni, Laura; Nasillo, Vincenzo; Messerotti, Andrea; Paolini, Ambra; Luppi, Mario |
| 7 | An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? | 2014 | Bigliardi, S; Morselli, M; Potenza, L; Bresciani, P; Cuoghi, A; Coluccio, V; Riva, G; Paolini, A; Fantuzzi, V; Faglioni, L; Nasillo, V; Messerotti, A; Marasca, R; Narni, F; Luppi, M; Forghieri, F |
| 8 | A typical atypical chronic myeloid leukemia | 2018 | Gilioli, Andrea; Paolini, Ambra; Bonacorsi, Goretta; Luppi, Mario |
| 9 | Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) | 2011 | Riva, Giovanni; Belletti, Daniela; Ruozi, Barbara; Barozzi, Patrizia; Vallerini, Daniela; Quadrelli, Chiara; Zanetti, Eleonora; Morselli, M; Forghieri, Fabio; Marasca, Roberto; Narni, Franco; Tosi, Giovanni; Forni, Flavio; Vandelli, Maria Angela; Potenza, Leonardo; Luppi, Mario |
| 10 | Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study | 2013 | Libri, I; Gnappi, E; Zanelli, P; Reina, M; Giuliodori, S; Vaglio, A; Palmisano, A; Buzio, C; Riva, G; Barozzi, P; Luppi, M; Cravedi, P; Maggiore, U |
| 11 | Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir | 2005 | Luppi M; Trovato R; Barozzi P; Vallisa D; Rossi G; Re A; Ravazzini L; Potenza L; Riva G; Morselli M; Longo G; Cavanna L; Roncaglia R; Torelli G |
| 12 | Translational challenges of human herpesvirus 6 chromosomal integration. | 2010 | Potenza, Leonardo; Barozzi, Patrizia; Torelli, G; Luppi, Mario |
| 13 | Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making | 2004 | Potenza L; Luppi M; Morselli M; Saviola A; Ferrari A; Riva G; Longo G; Marietta M; Torelli G |
| 14 | Three- or four-factor prothrombin complex concentrate for emergency anticoagulation reversal: what are we really looking for? | 2011 | Marietta M;Pedrazzi P;Luppi M |
| 15 | THE USE OF CYCLOSPORINE-A IN THE TREATMENT OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA - replay | 1995 | Emilia, G; Messora, C; Bensi, L; Luppi, Mario |
| 16 | The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. | 2010 | Cimino, G; Cenfra, N; Elia, L; Sica, S; Luppi, Mario; Meloni, G; Vignetti, M; Paoloni, F; Foà, R; Mandelli, F. |
| 17 | The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: An overview | 1996 | Luppi M; Torelli G |
| 18 | The human A-myb protein is a strong activator of transcription | 1994 | Golay J; Loffarelli L; Luppi M; Castellano M; Introna M. |
| 19 | Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib | 2015 | Maffei, Rossana; Fiorcari, Stefania; Martinelli, Silvia; Potenza, Leonardo; Luppi, Mario; Marasca, Roberto |
| 20 | T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature | 2019 | Alfano, G.; Fontana, F.; Colaci, E.; Mori, G.; Cerami, C.; Messerotti, A.; Potenza, L.; Luppi, M.; Cappelli, G. |
Nome completo:
LUPPI, Mario
Copyright © 2019